Nuvation Bio (NUVB) Collaborates with Thermo Fisher

Nuvation Bio Inc. (NYSE:NUVB) is one of the 10 Best Penny Stocks to Buy for Long Term.

On May 13, 2026, Nuvation Bio Inc. (NYSE:NUVB) announced the completion of the process technology transfer and product introduction to Thermo Fisher Scientific for IBTROZI-taletrectinib, for the treatment of advanced or metastatic ROS1-positive non-small cell lung cancer. The transition was submitted as a supplement to the IBTROZI New Drug Application held by Nuvation Bio and has now been completed.

Earlier in May, Nuvation Bio Inc. (NYSE:NUVB) reported Q1 EPS of 1c, versus the consensus estimate of 5c. Revenue totaled $83.23M, versus the consensus estimate of $62.34M. Founder, President, and CEO David Hung said the company was encouraged by ongoing launch trends for IBTROZI during the first quarter as adoption continued to expand across treatment lines for advanced ROS1-positive NSCLC. Hung also highlighted updated long-term follow-up data presented at the AACR meeting, which showed durability exceeding four years in TKI-naive patients, supporting physician confidence in selecting IBTROZI. In addition, management said the company recently secured exclusive global development and commercialization rights to safusidenib and plans to advance the pivotal Phase 3 SIGMA study in high-risk IDH1-mutant glioma. Nuvation Bio also expects to provide updates on its drug-drug conjugate platform later this year.

Nuvation Bio (NUVB) Collaborates with Thermo Fisher

Nuvation Bio Inc. (NYSE:NUVB) is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment.

While we acknowledge the risk and potential of NUVB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NUVB and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1